Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins / tetracyclines / succinylcholine / clozaril / calcium channel blocking agents-benzothiazepines / beta-adrenergic blocking agents attending: chief complaint: hematemesis major surgical or invasive procedure: micu admission hemodialysis history of present illness: 37 year old female with schizoaffective d/o, depression, seizure d/o, esrd from iga nephropathy, very poor access with transhepatic hd catheter on coumadin; now admit with ugib (melena, hematemesis). patient denies past history of hematemesis but noted to have some in last dc summary, no egd at that time. states hematemsis started today, melena last night. str notes of dark bloody stool x 3 incontinent episodes. sbp 111 at str. patient was receiving coumadin for line as detailed below; also started on fondaparineux 7.5 daily (appears to have received 3 doses only) for subtherapeutic inr. past medical history: esrd iga nephropathy schizoaffective disorder depression chronic anemia gerd cardiomyopathy: echo ef >65%, hyperdynamic, lvh, no valvular disease hypothyroidism gi bleed rle dvt seizure disorder tracheal stenosis s/p trach, on tm at 7l/min at rehab malignant hypothermia surgical history: s/p l upper and lower extremity av fistulae(failed), s/p r upper extremity av fistula (basilic vein transposition(failed), s/p r forearm av graft (failed), s/p attempted insertion of a peritoneal dialysis catheter (failed), central venous stenosis, innominate venous stenosis, s/p r brachioarterial->axillary av graft, nonfunctional, status post multiple thrombectomies and angioplasties, s/p tracheostomy, s/p thrombectomy of av graft x5, s/p transhepatic hd catheter placement social history: currently living at rehab. no tobacco, etoh, illicit drug use. family history: non-contributory physical exam: vitals: t98.5, 95/46, 105, 21, 100% on 50% tm general: alert, conversant, flat affect, nad heent: nc/at, perrl, mm moist, small dried blood in nares. neck: trach, no adenopathy lungs: coarse but clear, somewhat poor effort heart: slightly tachy, regular, no murmur appreciated abdomen: soft, nt/nd. r lateral transhepatic hd line. extrem: warm, no edema, l femoral line in place. neuro: alert and oriented to place pertinent results: 10:07pm hct-17.8* 10:07pm pt-16.6* ptt-31.9 inr(pt)-1.5* 03:21pm glucose-108* urea n-45* creat-4.1* sodium-139 potassium-5.4* chloride-107 total co2-24 anion gap-13 03:21pm alt(sgpt)-10 ast(sgot)-13 ld(ldh)-150 alk phos-80 tot bili-0.3 03:21pm albumin-2.7* calcium-7.6* phosphate-3.0 magnesium-1.4* 03:21pm vanco-16.6 03:21pm wbc-8.3 rbc-2.16* hgb-6.9* hct-20.3* mcv-94 mch-31.8 mchc-33.7 rdw-17.2* 03:21pm plt count-333 11:15am ctropnt-0.10* 11:15am ck(cpk)-15* brief hospital course: #ugib. the patient has had a history of gib, with last egd in . during her last admission previous to this, she again had a small amount of bleeding but was not scoped. this admission, the patient again complained of hematemesis in the setting of anticoagulation with fondaparinaux (however, normal inr due to prophlactic doses of 1mg coumadin daily to keep her transhepatic vein patent) given her esrd and recent fondaparinux doses which is renally cleared, the patient was at particulary high risk of bleeding. a discussion with heme-path was had and it was confirmed that there was no specific antidote for fondaparinux. therefore, the patient was monitored closely in the icu due to her gib and on the patient underwent an egd. at that time, a bleeding vessel was identified, possibly arterial in source, and the vessel was clipped and injected with epinephrine. following the egd, the patient had no clinical signs of active rebleeding and no further investigative radionuclear scans were needed. of note, the patient recieved a large amount of ffp and also recieved ~15 units prbc this admission. the patient was maintained on an iv ppi during this admission, which was switched to sucralfate after several days, and now is being considered for transfer back to rehab after several days of no hematemesis and stable hct. . # hypotension. at baseline, pt has a low blood pressure with sbp's running in the 80's - 100's. during this admission, the patient had episodes of hypotension below her baseline that were likely related to hypovolemia/blood loss from her large gib. bp was maintained with aggresive therapy with blood products. underlying infection/sepsis was considered but there was no evidence of active infection or this admission. the patient had two blood cultures on that were drawn from a left femoral line, and one of the two bottles showed gram negative and gram positive rods. the patient had been in the icu for several days when these results were received, and was improving clinically, without an elevated white count, so after discussion with the team, it was thought that this was most likely a contaminant. blood cultures redrawn are pending. the patient was continued on treatment with vancomycin that had been started during a previous admission for a mrsa bactermia in the past, with the plan to continue it with dialysis until . will tolerate sbp in the 80s-use hr as indicator for volume status as pt was tachycardic originally w acute bleed and has not been since. in addition, midodrine was stopped (had been on 5 mg tid prn for sbp < 90), can consider restarting in future. . # thrombocytopenia: new development this admission, platelets have continued to decrease but stabilized and recovered to the 130k range, 104 on discharge. effect was suspected to be medication related as fondaparineaux not usually associtaed with thrombocytopenia, and ppi was switched to carafate after which, an improvement in the patient's thrombocytopenia was noted. . # esrd on hd. hd m/w/f. history of extremely difficult access; currently accessed via transhepatic catheter. on low dose coumadin 1mg daily for this with no goal inr. pt was dialyzed during this admission without complication. . # history of line sepsis. pt continued to recieve vanco with hd while here and recieved an extra 500mg dose early during the admission secondary to her large volume blood loss and low vancomycin levels at that time. the course of vancomycin therapy was confirmed with id and the patient is to continue vancomycin with hd through . . # history of respiratory failure s/p trach. the patient's respiratory status was stable during this admission, she was continued on her trach mask at 40-50% fio2 with no issues while in the icu. . # hypothroidism. patient was continued on her synthroid. . # schizoaffective disorder/depression: patient was continued on her fluphenazine. . # gerd: on sucralfate, now off ppi/h2 blockers. . medications on admission: albuterol mdi 2 puffs qid calcium acetate 667 mg tid with meals cinacalcet 90 mg daily fluphenazine 2.5 mg , and 10 mg hs fondaparinux 7.5 mg daily (started ) levothyroxine 100 mcg daily midodrine 5 mg tid for sbp <90 pantoprazole 40 vancomycin 1 gram with hd (reportedly complete on ) warfarin 3 mg daily apap prn miconazole prn alteplase prn to hd cath discharge medications: 1. levothyroxine 100 mcg tablet sig: one (1) tablet po daily (daily). 2. fluphenazine hcl 2.5 mg tablet sig: one (1) tablet po bid (2 times a day). 3. fluphenazine hcl 10 mg tablet sig: one (1) tablet po hs (at bedtime). 4. cinacalcet 30 mg tablet sig: three (3) tablet po daily (daily). 5. calcium acetate 667 mg capsule sig: one (1) capsule po tid w/meals (3 times a day with meals). 6. albuterol 90 mcg/actuation aerosol sig: two (2) puff inhalation q6h (every 6 hours) as needed for wheeze. 7. acetaminophen 325 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for pain. 8. sucralfate 1 gram tablet sig: one (1) tablet po qid (4 times a day). 9. warfarin 1 mg tablet sig: one (1) tablet po daily (daily). 10. vancomycin 1000 mg iv hd protocol give one dose after hemodialysis session discharge disposition: extended care facility: & rehab center - discharge diagnosis: upper gastro-intestinal bleed secondary to bleeding esophageal vessel and esophagitis discharge condition: stable, trach in place discharge instructions: you were admitted to the hospital with a concern for bleeding. you underwent a procedure called an egd to control the bleeding. you also received blood transfusions to keep your blood level stable. . there were changes made to your medications. you will only take coumadin 1mg daily and not adjust this for your inr. in addition, you were started on sucralfate 1 g four times per day. this is to help protect your stomach given the recent bleed. your fondaparineux was stopped. . if you have any further bleeding, coughing up of blood, abdominal pain, shortness of breath, or other concerning symptoms, please return to the er. . you should follow up with your primary care doctor in the next 2-3 weeks. followup instructions: provider: , md phone: date/time: 9:00 provider: , md phone: date/time: 9:00 md procedure: venous catheterization, not elsewhere classified hemodialysis endoscopic excision or destruction of lesion or tissue of esophagus transfusion of packed cells transfusion of other serum diagnoses: other primary cardiomyopathies thrombocytopenia, unspecified end stage renal disease esophageal reflux unspecified septicemia iron deficiency anemia secondary to blood loss (chronic) unspecified acquired hypothyroidism depressive disorder, not elsewhere classified sepsis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure long-term (current) use of anticoagulants epilepsy, unspecified, without mention of intractable epilepsy anticoagulants causing adverse effects in therapeutic use esophagitis, unspecified hypovolemia other and unspecified infection due to central venous catheter esophageal hemorrhage schizoaffective disorder, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney 

Answer: The patient is high likely exposed to